Mangoceuticals (MGRX) Change in Accured Expenses (2023 - 2026)
Mangoceuticals (MGRX) reported Change in Accured Expenses of -$9191.0 for Q1 2026, down 102.7% on a YoY basis from $340678.0 in Q1 2025, and down 103.43% sequentially from $267985.0 in Q4 2025.
Mangoceuticals (MGRX) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 4 years of Change in Accured Expenses data on file, last reported at -$9191.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 102.7% year-over-year to -$9191.0; the trailing twelve-month figure through Mar 2026 stood at -$294200.0 (down 281.34% YoY), and the FY2025 full-year result was $55669.0, down 92.01% from the prior year.
- Change in Accured Expenses fell to -$9191.0 in Q1 2026, from $267985.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $875180.0 in Q1 2024 to a low of -$642810.0 in Q3 2025.
- A 4-year average of $65408.0 and a median of $51706.0 in 2023 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 6480.72% in 2024, while the deepest fall reached 1365.23% in 2024.
- Tracing MGRX's Change in Accured Expenses over 4 years: stood at $51706.0 in 2023, then soared by 1295.85% to $721736.0 in 2024, then tumbled by 62.87% to $267985.0 in 2025, then tumbled by 103.43% to -$9191.0 in 2026.
- Business Quant data shows MGRX's Change in Accured Expenses at -$9191.0 in Q1 2026, $267985.0 in Q4 2025, and -$642810.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 8.92 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 11.03 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | -873,000.00 |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | -20.60 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | -613,000.00 |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 67.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | -9.67 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | -35.25 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 49.11 Mn |
| 10 | Mangoceuticals | 9.39 Mn | 9.20 Mn | 29,001.00 | -9,191.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,191.00 |
| Mar 31, 2026 | -9,191.00 |
| Dec 31, 2025 | 267,985.00 |
| Dec 31, 2025 | 267,985.00 |
| Sep 30, 2025 | -642,810.00 |
| Sep 30, 2025 | -642,810.00 |
| Jun 30, 2025 | 89,816.00 |
| Jun 30, 2025 | 89,816.00 |
| Mar 31, 2025 | 340,678.00 |
| Mar 31, 2025 | 340,678.00 |
| Dec 31, 2024 | 721,736.00 |
| Dec 31, 2024 | 721,736.00 |
| Sep 30, 2024 | -602,885.00 |
| Sep 30, 2024 | -602,885.00 |
| Jun 30, 2024 | -297,295.00 |
| Jun 30, 2024 | -297,295.00 |
| Mar 31, 2024 | 875,180.00 |
| Mar 31, 2024 | 875,180.00 |
| Dec 31, 2023 | 51,706.00 |
| Dec 31, 2023 | 51,706.00 |